West Pharmaceutical Services, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $1.27 | $1.27 | $1.27 |
Q2 2024 | 2 | $1.74 | $1.74 | $1.74 |
Q3 2024 | 2 | $1.48 | $1.52 | $1.50 |
Q4 2024 | 6 | $1.65 | $1.83 | $1.71 |
Q1 2025 | 3 | $1.67 | $1.73 | $1.68 |
Q2 2025 | 2 | $1.80 | $1.88 | $1.83 |
Q3 2025 | 2 | $1.94 | $2.03 | $1.97 |
Q4 2025 | 2 | $2.05 | $2.14 | $2.08 |
Q1 2026 | 1 | $2.03 | $2.13 | $2.07 |
Q2 2026 | 1 | $2.19 | $2.29 | $2.23 |
Q3 2026 | 1 | $2.20 | $2.30 | $2.24 |
Q4 2026 | 1 | $2.27 | $2.38 | $2.31 |
West Pharmaceutical Services, Inc. Earnings Date And Information
West Pharmaceutical Services, Inc. last posted its earnings results on Thursday, October 24th, 2024. The company reported $1.85 earnings per share for the quarter, topping analysts' consensus estimates of $1.5 by $0.35. The company had revenue of 746.90 M for the quarter and had revenue of 2.95 B for the year. West Pharmaceutical Services, Inc. has generated $8 earnings per share over the last year ($7.88 diluted earnings per share) and currently has a price-to-earnings ratio of 46.76. West Pharmaceutical Services, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
West Pharmaceutical Services, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/24/2024 | Q3 2024 | $1.50 | $1.87 | 0.37 | $709.62 M | $746.90 M |
07/25/2024 | Q2 2024 | $1.74 | $1.52 | -0.22 | $729.36 M | $702.00 M |
04/25/2024 | Q1 2024 | $1.26 | $1.57 | 0.31 | $695.40 M | |
02/20/2024 | Q4 2023 | $1.85 | $732.00 M | |||
10/26/2023 | Q3 2023 | $1.86 | $2.17 | 0.31 | $750.31 M | $747.40 M |
07/27/2023 | Q2 2023 | $1.93 | $2.09 | 0.16 | $755.71 M | $753.80 M |
04/27/2023 | Q1 2023 | $1.67 | $1.88 | 0.21 | $716.60 M | |
02/21/2023 | Q4 2022 | $1.38 | $708.70 M | |||
10/27/2022 | Q3 2022 | $2.12 | $1.62 | -0.5 | $727.42 M | $686.90 M |
07/28/2022 | Q2 2022 | $2.21 | $2.53 | 0.32 | $754.25 M | $771.30 M |
04/28/2022 | Q1 2022 | $2.12 | $2.34 | 0.22 | $720.00 M | |
02/22/2022 | Q4 2021 | $1.98 | $730.80 M | |||
10/28/2021 | Q3 2021 | $1.80 | $2.37 | 0.57 | $687.09 M | $706.50 M |
07/30/2021 | Q2 2021 | $2.53 | $669.38 M | $723.60 M | ||
04/30/2021 | Q1 2021 | $2.04 | $670.70 M | |||
02/23/2021 | Q4 2020 | $1.33 | $580.20 M | |||
10/23/2020 | Q3 2020 | $1.11 | $502.72 M | $548.00 M | ||
07/24/2020 | Q2 2020 | $1.24 | $496.09 M | $527.20 M | ||
04/24/2020 | Q1 2020 | $1.01 | $491.50 M | |||
02/21/2020 | Q4 2019 | $0.86 | $470.60 M |
West Pharmaceutical Services, Inc. Earnings: Frequently Asked Questions
-
When is West Pharmaceutical Services, Inc.'s earnings date?
West Pharmaceutical Services, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
-
Did West Pharmaceutical Services, Inc. beat their earnings estimates last quarter?
In the previous quarter, West Pharmaceutical Services, Inc. (:WST) reported $1.85 earnings per share (EPS) to beat the analysts' consensus estimate of $1.5 by $0.35.
-
How can I listen to West Pharmaceutical Services, Inc.'s earnings conference call?
The conference call for West Pharmaceutical Services, Inc.'s latest earnings report can be listened to online.
-
How can I read West Pharmaceutical Services, Inc.'s conference call transcript?
The conference call transcript for West Pharmaceutical Services, Inc.'s latest earnings report can be read online.
-
How much revenue does West Pharmaceutical Services, Inc. generate each year?
West Pharmaceutical Services, Inc. (:WST) has a recorded annual revenue of $2.95 B.
-
How much profit does West Pharmaceutical Services, Inc. generate each year?
West Pharmaceutical Services, Inc. (:WST) has a recorded net income of $2.95 B. West Pharmaceutical Services, Inc. has generated $7.99 earnings per share over the last four quarters.
-
What is West Pharmaceutical Services, Inc.'s price-to-earnings ratio?
West Pharmaceutical Services, Inc. (:WST) has a price-to-earnings ratio of 46.76 and price/earnings-to-growth ratio is -11.08.